Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC .
Filed returns
123
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Janssen Sciences Ireland UC | Health | Engagement with the Departments of Health and Enterprise regarding the national life science strategy (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | Janssen Sciences Ireland UC | EU Affairs | Meeting with J&J Senior Leadership in Cork to discuss upcoming Irish Presidency of the EU and competitiveness (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | Janssen Sciences Ireland UC | Health | Meeting to discuss health products reimbursement process reform (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Government on J&J's economic contribution to Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | EU Affairs | Meeting to discuss EU Presidency Plans (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | EU Affairs | Meeting with Irish Perm Rep on Critical Medicines policy (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Taoiseach Micheál Martin (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meeting with Senator Teresa Costello (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meeting with Department of Health (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meetings with Government Ministers, parliamentarians, and officials with the US Chamber of Commerce delegation in February 2026 (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagements with Irish policymakers on national life sciences policy (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | EU Affairs | Engagements in relation to Biotech Act I (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Trade | Meeting with Minister Jack Chambers (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Justice and Equality | Meeting on third party litigation funding with Barry Andrews MEP (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Trade | Engagement with officials in Department of the Taoiseach (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | EU Affairs | Meeting with Maeve von Heynitz (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Minister Hildegarde Naughton (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Justice and Equality | Roundtable discussion on third-party litigation funding. (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Billy Kelleher MEP on the Critical Medicines Act (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister of State Thomas Byrne (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with the Taoiseach (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister Peter Burke (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with the Tánaiste (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Health | Engagement with the Department of Health on the Life Sciences Strategy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister Thomas Byrne on EU Presidency priorities (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members on patient access to new medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Tánaiste Simon Harris (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with HSE on IPHA Agreement and patient access to new medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Albert Nolan TD on biopharma policy priorities (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Industry meeting with Tánaiste on biopharmaceutical policy priorities (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Interactions with Fianna Fáil on the life sciences sector and patient access to new medicines (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Interactions with MEPs on EU and national life sciences policy (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Introductions to new Ministers outlining industry priorities (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Interaction with Secretary General of the Department of Health (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Communication with DETE on national strategy for the life sciences sector (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Courtesy call with an Taoiseach (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Communication with MEPs on outlook for the industry in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with EU Commissioner-Designate Michael McGrath (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Oireachtas members regarding the development of a national strategy for the life sciences sector (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Commissioner-designate Michael McGrath regarding TPLF (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Oireachtas members to promote shared industry priorities ahead of GE 2024 (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members re new development funding for medicines due for reimbursement in 2025. (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Health | Communication with Robert Watt re reimbursement process reform (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Health | Briefing for Opposition spokesperson on life sciences industry priorities. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | EU Affairs | Engagement with the Taoiseach on the review of the EU general pharmaceutical legislation. (Legislation) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Health | Engagement with John Lahart TD on the Mazars process to reform the reimbursement system (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Minister of State for Business on life sciences sector priorities (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | EU Affairs | Engagement with MEP candidate on revision of the EU general pharmaceutical legislation. (Legislation) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government & Oireachtas members re new medicines funding. (Matters involving public funds) | 7 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Conversation with Darren O'Rourke TD (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 58 | 47.2% | |
| Economic Development and Industry | 46 | 37.4% | |
| EU Affairs | 9 | 7.3% | |
| Budgetary matters | 4 | 3.3% | |
| Justice and Equality | 2 | 1.6% | |
| Trade | 2 | 1.6% | |
| Education and Training | 1 | 0.8% | |
| Public Expenditure and Reform | 1 | 0.8% |